L
LUCD
Lucid Diagnostics Inc.
0.6380
-0.0121-1.86%After Hours: 0.6639 +0.0259 +4.06%16:51 10/09 EDT
OPEN/PREV CLOSE0.6500/0.6501
TODAY RANGE0.6205-0.6897
VOL1.95M
MARKET CAP129.67M
52 WEEK RANGE0.5000-1.629
AVG VOL (3M)1.36M
% TURNOVER0.93%
TURNOVER--
P/E (TTM)-1.3603
% RANGE10.35%
EPS(TTM)-0.4690
P/E(FORWARD)-1.8493
P/B11.13
BVPS0.0573
DIVIDEND--
P/S17.77
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP97.38M
SHARES OUTSTANDING203.24M
NEXT EARNINGS11/10-11/16
FREE FLOAT152.63M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·10/01 21:06
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga·10/01 17:06
12 Health Care Stocks Moving In Thursday's Intraday Session
TipRanks·10/01 16:20
Needham sees no reason for Lucid Diagnostics selloff today
TipRanks·09/22 13:29
Lucid Diagnostics advances Medicare reimbursement and coding infrastructure
Benzinga·09/18 12:06
12 Health Care Stocks Moving In Friday's Pre-Market Session
Dow Jones·08/27 11:52
Lucid Diagnostics Is Maintained at Buy by Ascendiant Capital
TipRanks·08/27 11:45
Lucid Diagnostics price target raised to $9.50 from $9.25 at Ascendiant
TipRanks·08/22 00:27
Lucid Diagnostics Earnings Call Balances Progress and Risk
Benzinga·08/18 12:13
Lucid Diagnostics Could Be 'High In The Queue' For Medicare Coverage Decision, Analyst Says
Dow Jones·08/17 10:09
Lucid Diagnostics Price Target Maintained With a $2.50/Share by BTIG
Benzinga·08/17 09:59
BTIG Reiterates Buy on Lucid Diagnostics, Maintains $2.5 Price Target
TipRanks·08/17 07:54
Lucid Diagnostics reports Q2 non-GAAP EPS (6c), consensus (5c)
TipRanks·08/14 12:56
Lucid Diagnostics (LUCD) Receives a Buy from Maxim Group